Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Pfizer and AVANT Enter into Licensing and Development Agreement for Novel Therapeutic Vaccine Candidate for Brain Cancer
- NEW YORK & NEEDHAM, Mass. -- Pfizer, Inc (NYSE: PFE) and AVANT Immunotherapeutics (Nasdaq: AVAN), acting through its wholly-owned subsidiary Celldex Therapeutics, Inc. today announced that they have entered into an agreement under which Pfizer will be granted an exclusive worldwide license to a therapeutic cancer vaccine candidate, CDX-110, in...
- Research articles 2008-04-16
- nStor and Avant Networks Sign Distributor Agreement; nStor Selected by Avant to Bring Innovative, World-Class Storage Solutions to Asian Marketplace
- Business Editors & High-Tech Writers
- Research articles 2001-04-25
- Monterey Design Signs Agreement With Leading Distributor of EDA Products in Taiwan; Avant Technologies Selected as Exclusive Distributor Based On Proven Track Record of EDA Expertise
- Business Editors/High-Tech Writers
- Research articles 2002-10-01
- PFIZER Inc. and Avant Immunotherapeutics.(agreement to develop animal vaccines)(Brief Article)
- PFIZER Inc. and Avant Immunotherapeutics have formed an agreement to develop animal vaccines. Pfizer is paying $2.5 million in up-front licensing ... PFIZER Inc. and Avant Immunotherapeutics have formed an agreement to develop animal vaccines. Pfizer is paying $2.5 million in up-front licensing...
- Research articles 2000-12-04
- Avant Signs Agreement with Pfizer for Development of Animal Health Vaccines
- NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced today the signing of an extended collaborative research and development agreement with Pfizer Inc aimed at the discovery and development of vaccines to protect animals. The collaboration will employ vaccine technologies owned by AVANT.
- Research articles 2006-10-04
- << Previous
- page 1 of 1
- Next >>
